162 related articles for article (PubMed ID: 27778364)
1. Primary dermal pleomorphic liposarcoma: utility of adipophilin and MDM2/CDK4 immunostainings.
Ramírez-Bellver JL; López J; Macías E; Alegría-Landa V; Gimeno I; Pérez-Plaza A; Kutzner H; Requena L
J Cutan Pathol; 2017 Mar; 44(3):283-288. PubMed ID: 27778364
[TBL] [Abstract][Full Text] [Related]
2. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.
Mariño-Enríquez A; Hornick JL; Dal Cin P; Cibas ES; Qian X
Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706
[TBL] [Abstract][Full Text] [Related]
3. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
Thway K; Flora R; Shah C; Olmos D; Fisher C
Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
[TBL] [Abstract][Full Text] [Related]
5. Liposarcoma of the pleural cavity.
Kawai T; Nakashima H; Washimi K; Yokose T; Matsuo T; Nakayama M; Shinohara N; Kuroda H; Ishida K; Akiba J; Ishikawa M; Urabe S; Shiraishi J; Shiraishi T; Sakamoto A; Matsukuma S
Hum Pathol; 2023 Jun; 136():105-113. PubMed ID: 37023867
[TBL] [Abstract][Full Text] [Related]
6. Lipomas of the Oral Cavity: Utility of MDM2 and CDK4 in Avoiding Overdiagnosis as Atypical Lipomatous Tumor.
Stojanov IJ; Mariño-Enriquez A; Bahri N; Jo VY; Woo SB
Head Neck Pathol; 2019 Jun; 13(2):169-176. PubMed ID: 29748845
[TBL] [Abstract][Full Text] [Related]
7. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.
Chung L; Lau SK; Jiang Z; Loera S; Bedel V; Ji J; Weiss LM; Chu PG
Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885
[TBL] [Abstract][Full Text] [Related]
8. Histological Classification and Immunohistochemical Evaluation of MDM2 and CDK4 Expression in Canine Liposarcoma.
Avallone G; Roccabianca P; Crippa L; Lepri E; Brunetti B; Bernardini C; Forni M; Olandese A; Sarli G
Vet Pathol; 2016 Jul; 53(4):773-80. PubMed ID: 26993784
[TBL] [Abstract][Full Text] [Related]
9. Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours.
Aleixo PB; Hartmann AA; Menezes IC; Meurer RT; Oliveira AM
J Clin Pathol; 2009 Dec; 62(12):1127-35. PubMed ID: 19946100
[TBL] [Abstract][Full Text] [Related]
10. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).
Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L
Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065
[TBL] [Abstract][Full Text] [Related]
11. Dedifferentiated liposarcoma with meningothelial-like whorls, metaplastic bone formation, and CDK4, MDM2, and p16 expression: a morphologic and immunohistochemical study.
Thway K; Robertson D; Thway Y; Fisher C
Am J Surg Pathol; 2011 Mar; 35(3):356-63. PubMed ID: 21317707
[TBL] [Abstract][Full Text] [Related]
12. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.
Binh MB; Sastre-Garau X; Guillou L; de Pinieux G; Terrier P; Lagacé R; Aurias A; Hostein I; Coindre JM
Am J Surg Pathol; 2005 Oct; 29(10):1340-7. PubMed ID: 16160477
[TBL] [Abstract][Full Text] [Related]
13. Can HMGI-C be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics?
Alshenawy H
J Cancer Res Clin Oncol; 2013 Jun; 139(6):1073-81. PubMed ID: 23529275
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of p53 and MDM2 expressions in liposarcoma with World health organization classification.
Arici A; Ozgur T; Ugras N; Yalcinkaya U
Indian J Cancer; 2013; 50(3):164-9. PubMed ID: 24061453
[TBL] [Abstract][Full Text] [Related]
15. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification.
Lyle PL; Bridge JA; Simpson JF; Cates JM; Sanders ME
Histopathology; 2016 Jun; 68(7):1040-5. PubMed ID: 26542423
[TBL] [Abstract][Full Text] [Related]
16. Expanding the differential of cutaneous epithelioid tumors: A case of dedifferentiated liposarcoma with epithelioid features involving the skin, with review of the literature.
Chambers M; Badin DJ; Sriharan AA; Linos KD
J Cutan Pathol; 2020 Jun; 47(6):554-560. PubMed ID: 31995237
[TBL] [Abstract][Full Text] [Related]
17. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Utility and Limitations of Immunohistochemistry of p16, CDK4, and MDM2 and Automated Dual-color In Situ Hybridization of MDM2 for the Diagnosis of Challenging Cases of Dedifferentiated Liposarcoma.
Kobayashi A; Sakuma T; Fujimoto M; Jimbo N; Hirose T
Appl Immunohistochem Mol Morphol; 2019; 27(10):758-763. PubMed ID: 31145104
[TBL] [Abstract][Full Text] [Related]
19. Atypical lipomatous tumor/"well-differentiated liposarcoma" of the skin clinically presenting as a skin tag: clinicopathologic, immunohistochemical, and molecular analysis of 2 cases.
Paredes BE; Mentzel T
Am J Dermatopathol; 2011 Aug; 33(6):603-7. PubMed ID: 21358383
[TBL] [Abstract][Full Text] [Related]
20. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
